Live Breaking News & Updates on Worth Venture Partners

Stay updated with breaking news from Worth venture partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Masters Capital Management LLC Trims Stock Position in Aspen Aerogels, Inc. (NYSE:ASPN)

Masters Capital Management LLC trimmed its holdings in shares of Aspen Aerogels, Inc. (NYSE:ASPN – Free Report) by 59.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 200,000 shares of the construction company’s stock after selling 298,500 shares during […] ....

United States , Donaldr Young , Corbyc Whitaker , Aspen Aerogels Inc , Energy Industrial , Mesirow Institutional Investment Management Inc , Canaccord Genuity Group , Capital Management , Exchange Commission , Worth Venture Partners , Masters Capital Management , Securities Exchange Commission , Sora Investors , Hermes Inc , Aspen Aerogels , Free Report , Institutional Investment Management , Venture Partners , Get Free Report , Genuity Group , Aspen Aerogels Daily ,

K Charles Janac Sells 3,303 Shares of Arteris, Inc. (NASDAQ:AIP) Stock

Arteris, Inc. (NASDAQ:AIP – Get Free Report) CEO K Charles Janac sold 3,303 shares of the company’s stock in a transaction dated Tuesday, June 4th. The shares were sold at an average price of $7.70, for a total value of $25,433.10. Following the completion of the sale, the chief executive officer now directly owns 315,341 […] ....

K Charles Janac , Ceok Charles Janac , Asia Pacific , Silvercrest Asset Management Group , Worth Venture Partners , Vanguard Group Inc , Acadian Asset Management , Arteris Inc , Jefferies Financial Group , Capital Partners , Get Free Report , Charles Janac , Asset Management Group , Asset Management , Venture Partners , Integration Automation , Arteris Daily ,

Insider Buying: Neuronetics, Inc. (NASDAQ:STIM) Director Purchases 50,000 Shares of Stock

Neuronetics, Inc. (NASDAQ:STIM – Get Free Report) Director Robert Cascella bought 50,000 shares of Neuronetics stock in a transaction on Thursday, June 6th. The stock was acquired at an average price of $2.05 per share, with a total value of $102,500.00. Following the completion of the purchase, the director now directly owns 244,098 shares of […] ....

United States , William Blair , Piper Sandler , Robert Cascella , Worth Venture Partners , Dorsey Whitney Trust , Securities Exchange Commission , Sg Americas Securities , Fielder Capital Group , Neuronetics Inc , Investment Advisers , Get Free Report , Director Robert Cascella , Exchange Commission , Venture Partners , Whitney Trust , Capital Group , Neurostar Advanced Therapy System , Neuronetics Daily ,

Arteris, Inc. (NASDAQ:AIP) VP Sells $88,425.00 in Stock

Arteris, Inc. (NASDAQ:AIP – Get Free Report) VP Paul L. Alpern sold 11,250 shares of the firm’s stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $7.86, for a total value of $88,425.00. Following the completion of the transaction, the vice president now directly owns […] ....

Asia Pacific , Paull Alpern , Jefferies Financial Group , Citigroup Inc , Arteris Inc , Worth Venture Partners , Acuitas Investments , Hermes Inc , Acadian Asset Management , Get Free Report , Asset Management , Venture Partners , Federated Hermes , Integration Automation , Arteris Daily ,